Aspirin and diabetes prevention among healthy older adults—practice-changing or hypothesis-generating?
The global prevalence of diabetes—the vast majority of which is type 2 diabetes—increases steeply with age, affecting approximately one in four adults aged 75–79 years.1 As such, diabetes is an exceedingly common condition among older adults. Although younger populations generally experience the highest risk of adverse diabetes-related outcomes, owing to greater cumulative exposure, older adults with incident diabetes face an increased risk of premature death, cardiovascular disease, multimorbidity, and functional disability.